Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

Director of New UCSD Clinical Research Protections Program Appointed

 

November 07, 2005  |  

Michael P. Caligiuri, Ph.D., UCSD Professor of Psychiatry, has been named the first Director of the Clinical Research Protections (CRESP) Program at the University of California, San Diego (UCSD) Health Sciences, effective January 3, 2006.

The appointment was announced by Judith L. Swain, M.D., Director of UCSD’s College of Integrated Life Sciences and Dean for Translational Medicine and David N. Bailey, M.D., Deputy Vice Chancellor for Health Sciences and Dean, Faculty & Student Matters.

“We are fortunate to have attracted someone of Dr. Caligiuri’s caliber to this significant new position, and I look forward to working with him to make this program a national model,” said Swain.

CRESP is a new program that includes both the Human Research Protections Program, formerly headed by Daniel Masys, M.D., and the Research Compliance Office, formerly directed by Charles Mittman, M.D. The newly position has been created to provide better coordination of the activities of these two closely related programs and will further enhance the protection of people who participate in clinical research trials for new drug therapies and treatments.

Caligiuri is a nationally renowned researcher in neuro-psychiatric movement disorders.

He came to UCSD as a post-doctoral fellow in 1986 after earning his Ph.D. degree from the University of Wisconsin and joined the Division of Geriatric Psychology in 1988. A member of the UC San Diego Institutional Review Board (IRB) since 1997, Caligiuri has served as an IRB Vice Chair since 2004. He is a member the Society for Neuroscience, the International Organization for Brain Research, and the Society of Biological Psychiatry, among other professional organizations, and has published numerous original articles in the field of neuromuscular disorders related to psychiatric disturbances and psychopharmacologic mechanisms.

 

“Dr. Caligiuri has both the ability and the vision to ensure that UC San Diego Health Sciences continues on the path of excellence established by Dr. Masys.” said Bailey. “By combining research compliance and institutional review board functions under one individual, UCSD underscores its commitment to the highest scientific and ethical standards in clinical research.”

#  #  #

 

News Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu

Note to broadcast and cable producers: UCSD provides an on-campus satellite uplink facility for live or pre-recorded television interviews.  Please phone, or e-mail, the media contact listed above to arrange an interview.

UCSD Health Sciences Communications HealthBeat: /news/




Media Contact

Share This Article


Related News

10/22/2020
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer.
10/22/2020
In a recent study, researchers at University of California San Diego School of Medicine found a seventh component of wisdom: spirituality.
10/14/2020
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to ...
10/13/2020
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund t ...



Follow Us